KRAS and neoplasm: Most of the studies are retrospective case-control or cohort studies, and many others are larger registry studies where important stratification factors that might influence patients’ survival such as tumour sidedness and K-ras/B-raf/N-ras mutational status or, in some cases stage, at diagnosis are taken into account only partially.